Literature DB >> 26009567

Cost of disease-modifying therapies for multiple sclerosis.

Murray G Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26009567     DOI： 10.1212/WNL.0000000000001676

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

1.  Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic Evaluations.

Authors:  Luis Hernandez; Malinda O'Donnell; Maarten Postma
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

2.  Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015.

Authors:  Marcello Moccia; Raffaele Palladino; Roberta Lanzillo; Antonio Carotenuto; Cinzia Valeria Russo; Maria Triassi; Vincenzo Brescia Morra
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.